Thermo Fisher Scientific | TMO - Equity Capital And Reserves

Stock Price
503.46
Daily Change
13.96 2.85%
Monthly
-1.28%
Yearly
11.00%
Q2 Forecast
476.67

Thermo Fisher Scientific reported $53.54B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Agilent USD 6.91B 167M Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Bio-Rad Laboratories USD 7.45B 716.8M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.34B 139M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Henry Schein USD 3.24B 116M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Laboratory Of America USD 8.62B 93.2M Dec/2025
Medtronic USD 48.99B 128M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Myriad Genetics USD 368M 4.8M Dec/2025
Olympus JPY 773.35B 39.77B Dec/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Quest Diagnostics USD 7.17B 88M Dec/2025
Repligen USD 2.11B 1.66B Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Stryker USD 21.78B 594M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Veracyte USD 1.26B 36.61M Sep/2025
Waters USD 2.56B 230.55M Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025